We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Leronlimab in Moderately Ill Patients With COVID-19 Pneumonia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT04901676
Recruitment Status : Suspended (Pending DSMB evaluation)
First Posted : May 25, 2021
Last Update Posted : April 15, 2022
CytoDyn, Inc.
Information provided by (Responsible Party):
Hospital Israelita Albert Einstein

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Suspended
Estimated Primary Completion Date : January 2023
Estimated Study Completion Date : February 2023